155730-86-2

Upstream product

• 158669-35-3 (R)-(-)-1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-carboxylic acid 
• 133747-81-6 (+/-)-1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-carboxylic acid 
• 158898-08-9 (S)-N-[α-methyl(4-methyl)benzyl]-(R)-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-yl]carboxamide 

Downstream Products

• 155730-87-3 (R)-(-)-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4-yl]methyl methanesulfonate 
• 155730-89-5 (R)-(-)-methyl 4-{[1-(4-tert-butylphenyl)-2-oxo-pyrrolidin-4-yl]}methoxybenzoate 

Relevant academic research and scientific papers

Synthesis of the optical isomers of 4-[1-(4-tert-butylphenyl)-2- oxopyrrolidine-4-yl]methyloxybenzoic acid (S-2) and their biological evaluation as antilipidemic agent

The enantiomers of (±)-4-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine-4- yl]methyloxybenzoic acid (S-2), a new antilipidemic agent having dual action on the plasma triglyceride (TG) and cholesterol (Cho) lowering effects, were prepared via separation by Chir

1-phenylpyrrolidone derivatives having optical activity, intermediate for the preparation thereof and processes for their preparation

Disclosed are a 1-phenylpyrrolidone derivative having optical activity and represented by the formula (I) STR1 wherein R represents an optionally substituted optically active α-phenylethylamino group, a 1-phenylpyrrolidone derivative represented by the fo